Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

Share Price is delayed by 15 minutes
Get Live Data
81.90    -3.10 (-3.65%)
Bid:
81.90
Ask:
82.50
Spread: 0.60 (0.733%)
Market Cap: £134.27m
SYNT Live PriceLast checked at - London Stock Exchange

Intraday Synthomer Share Chart

Trading Update

2 Jul 2015 07:00

RNS Number : 9208R
Synthomer PLC
02 July 2015
 

2nd July 2015

Synthomer plc

Trading Update

Synthomer plc ('Synthomer' or 'the Group') today issues a Trading Update ahead of its Interim Results on Tuesday 11 August 2015.

Overall, the Board's expectations for the full year remain unchanged.

Europe and North America

In our Q1 trading update, we reported that volumes were slightly behind the same period in 2014. We continued to see a similar trend in Q2, with volumes lower than the prior period primarily due to weaker demand in our Paper and Carpets businesses. As expected, the small margin benefit we experienced in Q1 from declining raw material prices did not continue in Q2, as modest raw material price inflation returned. Overall, operating profit in our Europe and North America segment is marginally behind the prior period in local currency, further behind on a reported basis (H1 2014: £47.8m) due to the weak Euro and consequently slightly behind current market expectations.

Asia and Rest of World

Our Asia and Rest of World segment has continued to experience both improved unit margins and strong demand similar to that seen in the first quarter, particularly in our Asian nitrile business. We have seen good volume growth and substantial margin growth, relative to the weaker performance in the first half of 2014. As a result, operating profit in our Asia and Rest of World segment for the first half of 2015 is materially ahead of the prior period (H1 2014: £7.3m) and current market expectations.

Financial Position

The Group continues to generate strong cash flows from all its operations and this, together with the benefit of the translation of the Euro denominated debt, will result in a further significant reduction in net debt at the end of the first six months. 

The Final 2014 Ordinary Dividend of 4.8p per share and the Special Dividend of 7.8p per share will be paid on 3 July 2015 resulting in a total cash payment to shareholders of approximately £43m.

Outlook

Looking forward to the second half, the economic and currency challenges in Europe are expected to have a continued impact on performance. This will be offset by Asia and Rest of World where, despite some softening in market conditions at the end of the first half, we remain confident of a continued strong performance. Overall, the Board's expectations for the full year remain unchanged.

 

Enquiries:

 

Calum MacLean, Chief Executive Officer

Tel: 01279 436 211

Stephen Bennett, Chief Financial Officer

Tel: 01279 775 250

Charles Armitstead, Pendomer

Tel: 020 3603 5220

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTGMGGNVMVGKZM
Date   Source Headline
16th Oct 202010:33 amRNSHolding(s) in Company
14th Oct 20207:00 amRNSQ3 Trading Update
7th Oct 20209:20 amRNSHolding(s) in Company
4th Sep 20203:15 pmRNSDirector Declaration
6th Aug 20207:00 amRNSInterim Results for six months ended 30 June 2020
27th Jul 202010:00 amRNSPost Stabilisation Notice
16th Jul 20207:00 amRNSAppointment of Non-Executive Director
8th Jul 20204:16 pmRNSHolding(s) in Company
8th Jul 20204:14 pmRNSHolding(s) in Company
19th Jun 20207:00 amRNSSynthomer announces the pricing of senior notes
16th Jun 202011:54 amRNSPre Stabilisation Notice
16th Jun 202010:11 amRNSQ2 trading update
11th May 20205:21 pmRNSHolding(s) in Company
11th May 20209:03 amRNSDirector/PDMR Shareholding
11th May 20209:02 amRNSDirector/PDMR Shareholding
11th May 20208:59 amRNSDirector/PDMR Shareholding
11th May 20208:58 amRNSDirector/PDMR Shareholding
29th Apr 20203:17 pmRNSResult of AGM
29th Apr 20207:00 amRNSQ1 Trading and COVID-19 Update
1st Apr 20202:44 pmRNSCompletion of OMNOVA acquisition
1st Apr 20207:00 amRNSAnnual Financial Report
31st Mar 20207:00 amRNSDirector/PDMR Shareholding
31st Mar 20207:00 amRNSDirector/PDMR Shareholding
30th Mar 20207:00 amRNSAppointment of Deputy Chair and Chair-elect
30th Mar 20207:00 amRNSDirector/PDMR Shareholding
26th Mar 202010:17 amRNSEuropean Commission clearance for OMNOVA
23rd Mar 20207:00 amRNSDirector/PDMR Shareholding
16th Mar 20209:50 amRNSDirector/PDMR Shareholding
13th Mar 20205:29 pmRNSDirector/PDMR Shareholding
9th Mar 20202:45 pmRNSHolding(s) in Company
5th Mar 20207:00 amRNSPreliminary Results for the year ended 31 Dec 2019
31st Jan 20209:36 amRNSDirector Declaration
15th Jan 20202:21 pmRNSAcquisition of OMNOVA receives EC clearance
6th Dec 20197:00 amRNSAppointment of Broker
13th Nov 20192:53 pmRNSDirector/PDMR Shareholding
11th Nov 20197:00 amRNSDirector Declaration
25th Oct 20197:00 amRNSQ3 Trading Update
22nd Oct 20197:00 amRNSAGM Statement
11th Oct 20197:00 amRNSOmnova shareholders approval
14th Aug 20193:25 pmRNSHolding(s) in Company
13th Aug 201912:33 pmRNSDirector/PDMR Shareholding
6th Aug 20197:00 amRNSInterim Results for 6 months ended 30 June 2019
2nd Aug 201910:29 amRNSHolding(s) in Company
1st Aug 20199:05 amRNSHolding(s) in Company
31st Jul 201910:51 amRNSResults of Extraordinary General Meeting
30th Jul 20191:07 pmRNSDirector/PDMR Shareholding
30th Jul 20191:03 pmRNSDirector/PDMR Shareholding
30th Jul 20191:02 pmRNSDirector/PDMR Shareholding
30th Jul 20191:01 pmRNSDirector/PDMR Shareholding
30th Jul 201912:59 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.